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Abstract
Acinetobacter baumannii is an emergent and global nosocomial pathogen. In addition to A. baumannii, other Acinetobacter
species, especially those in the Acinetobacter calcoaceticus-baumannii (Acb) complex, have also been associated with serious
human infection. Although mechanisms of attachment, persistence on abiotic surfaces, and pathogenesis in A. baumannii
have been identified, the genetic mechanisms that explain the emergence of A. baumannii as the most widespread and
virulent Acinetobacter species are not fully understood. Recent whole genome sequencing has provided insight into the
phylogenetic structure of the genus Acinetobacter. However, a global comparison of genomic features between
Acinetobacter spp. has not been described in the literature. In this study, 136 Acinetobacter genomes, including 67
sequenced in this study, were compared to identify the acquisition and loss of genes in the expansion of the Acinetobacter
genus. A whole genome phylogeny confirmed that A. baumannii is a monophyletic clade and that the larger Acb complex is
also a well-supported monophyletic group. The whole genome phylogeny provided the framework for a global genomic
comparison based on a blast score ratio (BSR) analysis. The BSR analysis demonstrated that specific genes have been both
lost and acquired in the evolution of A. baumannii. In addition, several genes associated with A. baumannii pathogenesis
were found to be more conserved in the Acb complex, and especially in A. baumannii, than in other Acinetobacter genomes;
until recently, a global analysis of the distribution and conservation of virulence factors across the genus was not possible.
The results demonstrate that the acquisition of specific virulence factors has likely contributed to the widespread
persistence and virulence of A. baumannii. The identification of novel features associated with transcriptional regulation and
acquired by clades in the Acb complex presents targets for better understanding the evolution of pathogenesis and
virulence in the expansion of the genus.
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Introduction
Acinetobacter baumannii is a nosocomial pathogen implicated with
septicemia, pneumonia, and death [1,2,3]. A. baumannii is truly a
global pathogen, as it has been isolated from hospitals throughout
the world [4,5,6,7], as well as in wounded soldiers serving in Iraq
[8,9,10] and Afghanistan [11]. Acinetobacter is a genus in the
phylum Proteobacteria, family Moraxellaceae, consisting of 26
named species (http://www.bacterio.cict.fr/a/acinetobacter.
html). Acinetobacter spp. are found in most soil and water samples
[12], but are also a major source of nosocomial infections [13]; the
natural environments for the pathogens A. baumannii and A.
nosocomialis are not currently known [14]. Although most
nosocomial Acinetobacter infections are associated with A. baumannii
[15], other species have also been associated with human disease.
For example, A. ursingii has also been associated with nosocomial
bloodstream infections [16,17].
Our understanding of the pathogenesis of A. baumannii is largely
based on the ad-hoc analyses of putative virulence factors. Much
of the pathogenesis research in A. baumannii has focused on biofilm
formation [18,19], although no conclusive link between biofilm
formation and infection has been established [20]. Recent studies
have demonstrated that iron acquisition systems in A. baumannii are
important virulence factors [21]. Three distinct siderophore
systems associated with iron acquisition have been described in
A. baumannii [22,23]; the most well characterized of these systems is
acinetobactin, which shares homology to a plasmid-encoded
siderophore in Vibrio anguillarum [24,25]. A recent study demon-
strated that the proteins BasD and BauA, which are necessary for
acinetobactin synthesis, are required for the pathogen to persist
and ultimately kill host epithelial cells [26].
One of the primary concerns of A. baumannii as a nosocomial
pathogen is its resistance to antimicrobials [7]. Large antibiotic
resistance islands (RI), including the 86-kb RI in strain AYE [27],
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have been characterized in A. baumannii. Broad-spectrum beta-
lactamase genes [28], which are part of the carbapenem-
hydrolysing class D beta-lactamases (CHDLs) subgroup [29], have
been identified in A. baumannii, including blaOXA-51 [30], blaOXA-23
[31], and the plasmid-encoded gene blaOXA-58 [32]. In addition,
the expression of efflux pump systems, such as AdeFGH [33],
AdeABC [34], AdeIJK [35], and AdeM [36] has been associated
with multidrug resistance in A. baumannii.
Much of the research on the genus Acinetobacter has focused on
genomes in the Acinetobacter calcoaceticus-baumannii (Acb) complex
[37]. This complex includes A. baumannii, A. nosocomialis (originally
genomic species (gen. sp.) 13TU [38]), A. pittii (originally gen. sp. 3
[38]), A. sp. DR1 [39], and A. calcoaceticus. A. calcoaceticus and A. sp.
DR1 have not been implicated in serious human infection [14]. A
recent study of Acinetobacter bloodstream infections in the United
States demonstrated that the most common nosocomial infections
were caused by A. baumannii (63% of cases), A. nosocomialis (21% of
cases), and A. pittii (8% of cases) [40].
From a genomics perspective, most analyses of whole genome
sequence data have focused on multi-drug resistant (MDR) isolates
[41,42,43,44,45], although additional studies have considered
evolutionary relationships of A. baumannii [46,47]. In this study, a
large-scale whole genome sequence analysis was performed on a
set of previously characterized (n= 69), as well as newly sequenced
(n = 67), Acinetobacter genomes. These data were used to identify the
genomic diversity of the genus Acinetobacter and understand the flow
of genetic information between species in the genus. Prior to whole
genome sequence analysis, studying the conservation of diverse
genes across the genus was not possible. This information is not
only pertinent from a pathogenesis perspective, but may also aid in
the identification of targets important for diagnostic, therapeutic
and vaccine development.
Methods and Materials
Strain selection/clinical data
Sixty-seven Acinetobacter genomes were sequenced from a variety
of human and environmental sources (Table S1). Isolates were
selected to capture a broad range of genetic, geographic, and
temporal diversity and were not chosen based on specific clinical
outcomes. Species designations were applied by the position of the
isolate in the phylogeny and were not based on clinical typing
methods.
DNA isolation, sequencing, assembly
Acinetobacter isolates were grown on nutrient agar for 24 hours.
Genomic DNA was extracted following the manufacturer’s
protocol for Gram-negative bacteria in the Qiagen DNeasy Blood
and Tissue kit (Cat # 69504). DNA samples were prepared for
multiplexed, paired end sequencing following the manufacturer’s
protocol. For each isolate, 1–5 ug of dsDNA in 200 ul was sheared
and then purified using the QIAquick PCR Purification kit (Cat
#28106, Qiagen,Valencia, CA). Enzymatic processing of the
DNA followed the guidelines as described in the Illumina protocol,
but enzymes for processing were obtained from New England
Biolabs (Cat #E6000L, New England Biolabs, Ipswich, MA) and
the oligonucleotides and adaptors were obtained from Illumina
(Cat #PE-400-1001). After ligation of the adaptors, the DNA was
run on a 2% agarose gel for 2 hours, after which a gel slice
containing 500–600 bp fragments of each DNA sample was
isolated and purified using the QIAquick Gel Extraction kit (Cat
#28706, Qiagen, Valencia, CA). Individual libraries were
quantified with qPCR on the ABI 7900HT (Part #4329001, Life
Technologies Corporation, Carlsbad, CA) using the Kapa Library
Quantification Kit (part # KK4832 or KK4835, Kapa Biosys-
tems, Woburn, MA). Based on the individual library concentra-
tions, equimolar pools of libraries were prepared at a concentra-
tion of at least 1 nM. The pooled libraries were sequenced on the
Illumina GA-IIx using the ‘‘Genomic DNA sequencing primer
V2’’ protocol for 36 cycles. A 100 bp paired-end run was used for
all isolates.
Paired-end sequence reads were assembled with Velvet [48], in
conjunction with the VelvetOptimiser (http://bioinformatics.net.
au/software.velvetoptimiser.shtml). Contigs shorter than 200
nucleotides were filtered from the assembly. Errors in each
assembly were corrected with iCORN [49]. Assembly statistics are
detailed in Table S1.
Whole genome phylogeny of the genus Acinetobacter
136 genomes were processed with the kSNP analysis tool [50],
which generated a multiple sequence alignment based on single
nucleotide polymorphisms (SNPs). This alignment included SNPs
from 69 reference genomes (Table S2) and 67 genomes sequenced
in this study (Table S1). Singleton and homoplastic SNPs were
removed from the alignment with noisy [51] using the ‘‘nogap’’
setting. A tree was inferred on this reduced alignment with
FastTree2 [52], using the following parameters: -spr 4 -mlacc 2 –
slownni. The tree was rooted by A. radioresistens in FigTree (http://
beast.bio.ed.ac.uk/FigTree).
Blast score ratio (BSR) analysis
Contigs from draft assemblies were concatenated with a linker
(NNNNNCACACACTTAATTAATTAAGTGTGTGNNNNN)
inserted between each contig; this linker contains a start/stop
codon in all 6 frames. Coding regions (CDSs) were predicted using
Glimmer3 [53]. CDSs from each genome were concatenated and
then de-replicated by clustering with USEARCH [54], using an
ID of 0.8 and an IDDEF value of 3. Low-density clusters (n,4)
were removed to reduce the size of the dataset. Each represen-
tative cluster was then translated with transeq [55]; the translated
sequence was then aligned against each genome in the dataset with
TBLASTN [56]. The query bit score for each genome alignment
was divided by the maximum bit score in all genomes to obtain the
blast score ratio (BSR) [57]; the BSR value can range from 1.0
(100% ID across 100% of the peptide) to 0 (no significant
alignment).
In silico gene screen
To identify the conservation of specific genes associated with
virulence (Table S3) across the genus Acinetobacter, the peptide
sequence for each virulence factor was aligned against all
sequenced genomes with TBLASTN. The BSR values across
groups were visualized with the multi-experiment viewer [58].
Raw BSR values for each marker screened in this study are listed
in Table S4.
Multi-locus sequence typing (MLST) phylogeny
For a comparison to the whole-genome phylogeny, a tree was
inferred from concatenated MLST sequences. Sequences from
MLST markers were downloaded (gltA, gyrB, gdhB, recA, cpn60, gpi,
rpoD) from the A. baumannii pubMLST database (pubmlst.org/
abaumannii). Sequences were extracted from BLAST alignments,
concatenated, aligned with MUSCLE [59], and a phylogeny was
inferred with FastTree2, as has been done previously [60].
Acinetobacter Gene Composition
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16S rRNA gene sequence analysis
For an additional comparison to the whole genome phylogeny,
a tree was inferred from an alignment of 16S rRNA gene
sequences. Sequences were extracted from all genomes with SSU-
ALIGN (http://selab.janelia.org/software.html), which is based
on a covariance model implemented in Infernal [61]. These
sequences were combined with reference sequences in the
Greengenes database [62]. Gene sequences were exported from
ARB [63] and all sequences were aligned with SSU-ALIGN.
Homoplastic and singleton SNPs were removed from the
alignment with noisy. A tree was inferred with FastTree2, using
the same parameters as with the whole genome phylogeny.
Monophyletic clades were collapsed in ARB. Sequences from a
basal branch in the Gammaproteobacteria were used to root the
phylogeny.
Results
Whole genome sequencing of 67 new Acinetobacter
genomes
In order to expand the Acinetobacter phylogeny, 67 genomes were
sequenced and analyzed. While most sequenced isolates (n = 47)
were identified as A. baumannii, genomes (n = 20) from other species
were included. These genomes represent a significant addition of
genomic data from the genus and will serve as a valuable resource
for future genomic studies.
Whole genome phylogeny of the genus Acinetobacter
A whole genome phylogeny was inferred on ,200,000 single
nucleotide polymorphisms (SNPs) identified by kSNP (Figure 1).
This phylogeny represents the most comprehensive global
phylogeny of Acinetobacter based on whole genome sequencing
and is consistent with a recent study of Acinetobacter evolution [64].
The results confirm that A. baumannii genomes comprise a
monophyletic clade that is part of the larger Acinetobacter
calcoaceticus-baumannii (Acb) complex. In addition to pathogens, the
Acb complex contains environmental isolates not associated with
serious human disease [65]; the three isolates sequenced in this
study (A. calcoaceticus TG19593, TG19585, TG19588) from the
environmental clade, including A. calcoaceticus and A. sp. DR1, are
soil isolates not associated with serious human infection.
The phylogeny was rooted with A. radioresistens, which has also
shown to be the root for a tree inferred from rpoB sequences [38]
and from an amplified fragment length polymorphism (AFLP)
analysis [66]. The 16S rRNA gene sequence phylogeny inferred in
this study supports A. radioresistens as the most basal clade of
previously sequenced Acinetobacter spp. (Figure S1). A phylogeny
inferred from a concatenation of multi-locus sequence typing
(MLST) markers revealed a similar topology to the whole genome
phylogeny in the Acb complex (Figure S2).
Genome size differences in Acinetobacter species
To determine differences in genome size at specific nodes in the
phylogeny, genome assembly sizes (Table S1) were compared
between the Acinetobacter root (A. radioresistens), the Acb complex, and
the remaining Acinetobacter clade (Figure 1). The radioresistens clade
had the smallest average genome size (3.21, 95% CI+/20.13 mb),
while the Acb complex had the largest (3.94, 95% CI+/20.05 mb);
the remaining Acinetobacter clade was intermediate in size (3.5, 95%
CI+/20.13 mb).
Gene gain/loss in the Acb complex
Based on the average genome size, the Acb complex has
acquired a complement of genes compared to all other sequenced
Acinetobacter species. To identify genes that were gained and lost in
the Acb complex, a blast score ratio (BSR) analysis with peptide
sequences was performed. For a gene to be considered as acquired
by a lineage, we required a BSR value $0.8 in .85% of targeted
genomes and a BSR value ,0.4 in .95% of non-targeted
genomes; a BSR value = 0.8 is approximate to 80% peptide
identity over 100% of the peptide length [67]. Genomic targets
that met these criteria were tabulated (Table 1). The peptide
sequence for each gene was aligned against all genomes (n = 136)
with TBLASTN [56]. The results demonstrate that each gene is
specific to each targeted group based on the BSR analysis
(Figure 2).
Genes unique to the Acb complex (Table 1, Figure 2) include a
multidrug resistance protein, a multidrug resistance transporter,
and an AraC-family transcriptional regulator. Genes either not
acquired or lost by the complex include a tellurite-resistance gene
and a urea ABC transporter (Table 1) that shares homology
(.80% identity over 100% of the peptide length) to membrane
transporters in other Pseudomonads. Additional genes shared
homology to hypothetical proteins with no known function.
Genes were also identified that are conserved in the nosocomialis-
baumannii clade, but are absent from other genomes in the Acb
complex. Genes unique to this clade include a class A beta-
lactamase (TEM-1), a GntR-family transcriptional regulator
(ABAYE1931), and conserved hypothetical proteins (Table 1);
the acquired transcriptional regulator shares homology (56% ID
over 100% of the peptide length) with a transcriptional regulator
(bgla_2g16570) in the plant pathogen, Burkholderia gladioli [68].
Genes lost by this sub-clade include a bile acid sodium symporter
associated with resistance to arsenic compounds [69] (Table 1).
Genes unique to the A. baumannii clade include hypothetical
proteins and a GntR family (FCD domain) transcriptional
regulator (ABAYE1316); this regulator shares homology (39%
ID over 96% of the peptide length) with a regulator (PST_2058) in
the opportunistic pathogen, Pseudomonas stutzeri [70]. Genes lost in
A. baumannii include a glyoxylase/bleomycin resistance gene and a
specific ECF-type RNA polymerase sigma factor. The functions of
acquired hypothetical proteins in the Acb complex are not
currently known; however, several of these peptides share
homology with genes in known pathogens (Table S5).
Siderophore distribution and conservation in the genus
Acinetobacter
One identified pathogenic mechanism of A. baumannii infection
is through the expression of siderophores [24]. However, the
conservation of siderophore genes across the Acinetobacter genus is
not currently known. The acinetobactin iron acquisition cluster,
which consists of 25 kb of sequence in seven operons [71], in A.
baumannii AYE (Table S3) [27], was aligned against all Acinetobacter
genomes analyzed in this study with TBLASTN. Genes screened
included BasD [25], and BasE, which activates the 2,3-dihydrox-
ybenzoic acid molecule and transfers it to BasF [72]. The
acinetobactin cluster was highly conserved in A. baumannii and
the clade that includes A. pittii (Figure 3); homologous peptides
were also observed in several A. haemolyticus isolates, as has been
previously observed [72]. The A. baumannii clade also contains
siderophore cluster 1 (ABAYE2001-2008) [21] that appears to be
unique to A. baumannii (Figure 3). Components of the acinetoferrin
system are conserved in the A. haemolyticus clade [73]; four
components of the acinetoferrin cluster are homologous to
peptides in A. baumannii (Figure 3). In addition to siderophore
Acinetobacter Gene Composition
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genes, the A. baumannii-nosocomialis clade also contains a unique
TonB-dependent siderophore receptor protein (ABAYE1644)
(Figure 3); these proteins are involved in sensing extra-cellular
signals and responding through transcriptional regulation [74].
Carbapenem-hydrolyzing oxacillinases (OXA)
Antibiotic resistance is common in nosocomial A. baumannii
infections [75]. One mechanism of resistance to beta-lactams,
including carbapenems, in A. baumannii is through the expression of
OXA-type enzymes [14]. To determine their distribution, OXA
genes (Table S3) were informatically screened against all
sequenced Acinetobacter genomes. Only blaOXA-51-like [30] genes
were found to be conserved across the majority of Acinetobacter spp.
(Figure 4); genomes from the nosocomialis and baylyi clades lack a
blaOXA-51 homolog (Table S4). The blaOXA-51-like genes are
specific to each species and have been proposed as a method of
positively identifying A. baumannii isolates [76]. An in silico screen
demonstrated that blaOXA-51-like primers [76] not only align with
all A. baumannii genomes (n = 89) analyzed in this study, but do not
significantly align with any other Acinetobacter spp. (n = 47),
including non-baumannii genomes in the Acb complex.
Figure 1. A whole genome phylogeny of 136 sequenced genomes in the genus Acinetobacter. The phylogeny was inferred with FastTree2
[52] on a single nucleotide polymorphism (SNP) matrix alignment calculated with kSNP [50] and filtered with noisy [51]. The phylogeny was rooted
with A. radioresistens. Genomes sequenced in the current study are shown in red. Genomes in the Acinetobacter calcoaceticus-baumannii (Acb)
complex are colored by clade.
doi:10.1371/journal.pone.0054287.g001
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In A. baumannii isolates that only contain blaOXA-51-like genes, the
presence of the insertion element ISAba1 is required for
carbapenem resistance [77]. For example, the multi-drug suscep-
tible genomes AB058, A118, AB900 and AB307-0294 are all
blaOXA-51-like positive and ISAba1 negative (Table S4). While
ISAba1 appears to be conserved in A. baumannii, a BSR analysis
demonstrated that the insertion element is also present in other
Acinetobacter spp. (Figure 4).
Discussion
The genus Acinetobacter contains a mixture of non-pathogenic
environmental isolates and wide-spread nosocomial pathogens
[78]. Although other Acinetobacter spp. have been implicated in
human infection, A. baumannii appears to be the most widespread
and virulent. With the advent of whole-genome sequencing and
large-scale comparative analyses, the genomic differences between
A. baumannii and related isolates can now be identified. The current
study represents the most comprehensive comparative analysis of
the conservation and distribution of virulence factors across the
Acinetobacter genus performed to date.
The Acinetobacter whole genome phylogeny confirms that the A.
calcoaceticus-baumannii (Acb) complex is monophyletic (Figure 1).
Isolates from this complex are frequently associated with
nosocomial infections [40,79]. However, isolates from the
calcoaceticus clade (Figure 1) are typically environmental isolates
not associated with serious human infection [14]. In addition, A.
pittii strain PHEA-2, was isolated from industry wastewater [80].
From a clinical perspective, the identification of Acb complex
isolates, which include both environmental isolates and human
pathogens, may be misleading from a treatment perspective [14].
Genomic regions identified in this study and guided by a whole
genome phylogeny may provide better discrimination between
related stains of varying clinical significance. The identification of
clinical isolates based on acquired genes on specific phylogenetic
branches may help to develop diagnostics that can accurately
classify infections from nosocomial Acinetobacter pathogens.
Whole genome sequence analysis of 136 Acinetobacter genomes
has provided a comprehensive view of Acinetobacter evolution.
Based on the analysis of several conserved genes, A. radioresistens is
the most basal lineage of sequenced Acinetobacter genomes. In
addition, the A. radioresistens clade was shown to have the smallest
average genome size where the Acb complex has the largest.
Although genome reduction is generally associated with a
pathogenic lifestyle [81], genome expansion in pathogens has also
been observed [82]. While the functional roles of all acquired
genes in A. baumannii have not yet been determined, they may be
associated with the persistence and virulence of A. baumannii in
hospital environments.
A. baumannii thrives in hospital settings, largely due to its
persistence on abiotic surfaces [83]. One mechanism for A.
baumannii persistence in hospital settings is the presence of a
putative tip adhesion gene, csuE. The csuE gene (ABK1_1276) is
involved in pilus and biofilm formation [19] and is largely
conserved (BSR.0.8) in the A. baumannii (.92% presence), A.
nosocomialis (100% presence), and A. pittii (67% presence) clades;
csuE is absent (BSR,0.4) from environmental isolates in the
calcoaceticus clade as well as Acinetobacter genomes not in the Acb
complex (Table S5). The presence of this gene has been associated
with the persistence of A. baumannii on abiotic surfaces, such as
plastic and glass [19]. The lack of a homologous gene in non-Acb
isolates could explain why pathogens in the Acb complex persist in
the hospital environment. Furthermore, A. baumannii can survive
desiccation much better than most other Acinetobacter spp. [84];
however, A. radioresistens has been shown to be perhaps the most
desiccation-tolerant Acinetobacter spp. [85]. This suggests a mech-
anism for attachment, as well as persistence, on abiotic hospital
surfaces.
Figure 2. A heatmap of blast score ratio (BSR) [57] values for branch specific regions in the Acb complex. BSR values were visualized
with the multi-experiment viewer [58]. Samples were clustered using an average linkage clustering algorithm. Numbers for each feature correlate
with features described in Table 1. Raw data values are shown in Table S5.
doi:10.1371/journal.pone.0054287.g002
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The role of siderophores in bacterial pathogenesis is well
characterized [86]. When A. baumannii invades the host, one
mechanism of persistence and toxicity is the acinetobactin iron-
acquisition system [24]. Although not unique to A. baumannii, the
acinetobactin cluster is well conserved in the species and is likely a
contributing factor in A. baumannii survival and pathogenesis.
Three unique iron-acquisition systems have been identified in A.
baumannii including siderophore cluster 1, which appears to be
unique to A. baumannii (Figure 3). In a study of gene expression in
iron-limited media, all three iron acquisition systems identified in
A. baumannii were up regulated [21]. The presence of multiple iron
Table 1. Annotation details of lost and acquired genes in the evolution of A. baumannii.
feature locus_tag annotation clade* type
1 ABAYE2283 lipase Acb gain
2 ABAYE0080 signal peptide Acb gain
3 ABAYE3752 porin Acb gain
4 ABAYE3753 efflux pump membrane transporter Acb gain
5 ABAYE3761 autoinducer synthesis protein Acb gain
6 ABAYE2829 aldose 1-epimerase Acb gain
7 ABAYE1524 Lactonase Acb gain
8 ABAYE1477 chorismate mutase Acb gain
9 ABAYE2143 hypothethical Acb gain
10 ABAYE0743 hypothethical Acb gain
11 ABAYE1358 multidrug resistance protein Acb gain
12 ABAYE1778 multidrug resistance transporter Acb gain
13 ABAYE0223 AraC family transcriptional regulator Acb gain
14 ACICU_01049 hypothethical b gain
15 ABAYE2708 hypothethical b gain
16 HMPREF0022_02462 hypothethical b gain
17 ACICU_02424 ATPase b gain
18 ABAYE1316 GntR family transcriptional regulator b gain
19 ABAYE2003 hypothethical b gain
20 AbauAB05_010100017737 hypothethical b gain
21 AbauAB059_010100020508 hypothethical b,n gain
22 HMPREF0022_00070 hypothethical b,n gain
23 ABZJ_00026 hypothethical b,n gain
24 AbauAB0_010100001652 hypothethical b,n gain
25 ABAYE2456 beta-lactamase b,n gain
26 HMPREF0021_00524 hypothethical b,n gain
27 ABAYE0983 hypothethical b,n gain
28 ABAYE1931 GntR family transcriptional regulator b,n gain
29 HMPREF0012_03541 hypothethical b loss
30 HMPREF0012_00124 glyoxylase b loss
31 HMPREF0012_00560 hypothethical b loss
32 HMPREF0012_00562 RNA polymerase sigma factor b loss
33 HMPREF0023_2071 bile acid:sodium symporter b,n loss
34 HMPREF0013_03409 hypothethical b,n loss
35 HMPREF0013_03179 hypothethical b,n loss
36 HMPREF0013_03184 3-hydroxyisobutyrate dehydrogenase b,n loss
37 HMPREF0012_01063 hypothethical b,n loss
38 HMPREF0026_02170 urea ABC transporter Acb loss
39 HMPREF0026_00688 tellurite resistance protein Acb loss
40 HMP0015_2881 hypothethical Acb loss
41 HMPREF0026_01273 methanol dehydrogenase regulatory protein Acb loss
42 HMPREF0023_2956 amidase Acb loss
*Acb=Acinetobacter calcoaceticus-baumannii, b = baumannii, n = nosocomialis.
doi:10.1371/journal.pone.0054287.t001
Acinetobacter Gene Composition
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acquisition systems could provide a competitive advantage for the
pathogen over other host microbiota.
Antibiotic resistance may be the most troubling aspect in the
evolution of the Acb complex. A unique gene acquired in the
evolution of A. baumannii, compared to other Acinetobacter spp., is a
narrow-spectrum TEM-1 beta-lactamase, which is highly con-
served in A. baumannii and A. nosocomialis; however, the clinical
significance of this gene acquisition is unclear [14]. What is of
great concern is the resistance of A. baumannii to broad-spectrum
antibiotics, such as fluoroquinolones, especially in outbreak events
[87]. Beta-lactamase genes are conserved in A. baumannii [88],
which allow the bacterium to persist in the host and resist
treatment therapies. Efflux pumps are also important mechanisms
for antibiotic resistance in A. baumannii [42]; a comparative analysis
demonstrated that A. baumannii contains an assortment of efflux
pump genes that are not well conserved outside of the Acb complex
(Figure 4). Although additional mechanisms of resistance, includ-
ing 16S rRNA methylation [89], have been described for A.
baumannii, they are more difficult to identify through comparative
genomic analyses.
In addition to these known mechanisms of persistence,
colonization, and infection, additional currently un-identified
mechanisms likely play a role in the pathogenesis of A. baumannii
and related isolates. In this study, transcriptional regulators have
been identified that are unique to specific nodes in the Acb
complex and have unknown regulatory function (Table 1); several
of these regulators share homology with regulators in other
pathogens, which suggests a role of these genes in A. baumannii
pathogenesis. Characterization of these regulators with a global
and an un-biased approach, such as RNA-sequencing [90], may
be required in order to better understand the regulatory networks
of A. baumannii; these experiments are currently on-going.
Population level whole genome sequencing has provided a
comprehensive tool for the analysis of Acinetobacter evolution.
Furthermore, the established whole genome phylogeny has
provided insight into important evolutionary relationships that
cannot be fully determined with single gene or MLST analysis.
The comparative method described in this study demonstrates
how whole genome sequence analysis can be used to study the flow
of genomic information between species in a genus, thereby
allowing for an understanding of the evolution of an environmen-
tal microbe into a nosocomial pathogen. Guided by a whole-
genome phylogeny, this flow of information can then be used to
focus studies on the functional characterization of novel genomic
features and determine their role in pathogenesis. This method
Figure 3. A heatmap of blast score ratio (BSR) [57] values for iron acquisition genes in Acinetobacter. BSR values were visualized with the
multi-experiment viewer [58]. Accession details for each gene in specific iron acquisition systems are shown in Table S3, with raw data shown in Table
S5.
doi:10.1371/journal.pone.0054287.g003
Figure 4. A heatmap of blast score ratio (BSR) [57] values for efflux pump and beta-lactamase genes identified in Acinetobacter. BSR
values were visualized with the multi-experiment viewer [58]. Accession details for each gene are shown in Table S3, with raw data shown in Table S5.
doi:10.1371/journal.pone.0054287.g004
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represents a new paradigm in the identification and characteriza-
tion of emerging human pathogens, such as A. baumannii.
Supporting Information
Figure S1 A phylogenetic tree inferred from an align-
ment of 16S rRNA gene sequences. The tree was inferred
with FastTree2 with 1000 bootstrap replicates; bootstrap support
values are shown at nodes. Clades were collapsed in ARB [63].
(TIF)
Figure S2 A comparison of phylogenetic trees inferred
on either a whole genome alignment, or an alignment of
concatenated multi-locus sequencing typing (MLST)
(pubmlst.org/abaumannii) sequences informatically ex-
tracted from each genome analyzed in this study. Trees
were inferred with FastTree2 [52]. Clades were colored based on
assignments made from the whole genome phylogeny.
(TIF)
Table S1 Details of isolation, assembly, and accession
of isolates sequenced in this study.
(PDF)
Table S2 Accession details of reference genomes ana-
lyzed in this study.
(PDF)
Table S3 Accession and annotation details for genes
screened in this study.
(PDF)
Table S4 Raw blast score ratio (BSR) for each gene
screened in this study.
(PDF)
Table S5 Homology of acquired genes in the Acineto-
bacter calcoaceticus-baumannii (Acb) complex to genes
in other bacteria.
(PDF)
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